Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

183.87
Delayed Data
As of Mar 24
 +0.16 / +0.09%
Today’s Change
147.74
Today|||52-Week Range
186.11
+11.07%
Year-to-Date
No recent news for Becton Dickinson and Co.

Today’s Trading

Previous close183.71
Today’s open183.67
Day’s range183.42 - 185.09
Volume658,057
Average volume (3 months)1,034,256
Market cap$39.1B
Dividend yield1.59%
Data as of 4:02pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+34.03%
Earnings growth (this year)+9.75%
Earnings growth (next 5 years)+10.16%
Revenue growth (last year)+21.41%
P/E ratio30.6
Price/Sales3.13
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...+0.07+0.29%
ZBHZimmer Biomet Holdin...+0.26+0.22%
BCRC R Bard Inc+1.18+0.47%
TFXTeleflex Inc+0.08+0.04%
Data as of 4:05pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$2.23
Annual revenue (last year)$12.5B
Annual profit (last year)$976.0M
Net profit margin7.82%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts


Search for Jobs